- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
September 16th, 2004
Biophan Technologies, Inc., a developer of next-generation biomedical technology, has appointed biotechnology executive John Lanzafame to serve as president of the Company's Nanolution division, according to Biophan CEO Michael Weiner.
As Nanolution president, Mr. Lanzafame will oversee Biophan's development of advanced nanotechnology-based drug delivery devices and drug-elution technologies, patents, and products.
|Related News Press|
Silk bio-ink could help advance tissue engineering with 3-D printers September 2nd, 2015
Phagraphene, a 'relative' of graphene, discovered September 2nd, 2015
National Space Society Welcomes Geoff Notkin As New NSS Governor August 26th, 2015
Markus Lusser is New President of Leica Microsystems August 11th, 2015